Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 3Phase NA 1

Status

Recruiting 3Withdrawn 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Breast 2Gynecologic 1

Conditions

Prostatic Neoplasms 2Breast Neoplasms 2Ovarian Neoplasms 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Carboplatin 98Cisplatin 95pembrolizumab 90Gemcitabine 81Paclitaxel 80Docetaxel 73Capecitabine 64Oxaliplatin 53Specimen Handling 52Fluorouracil 52Magnetic Resonance Spectroscopy 50Bevacizumab 49Radiotherapy 48Dexamethasone 45Cyclophosphamide 44Leucovorin 39Drug Therapy 39Irinotecan 37Doxorubicin 36Pemetrexed 35Injections 30Trastuzumab 28Vincristine 27Rituximab 27Radiosurgery 25Prednisone 25Etoposide 25130-nm albumin-bound paclitaxel 25Radiation 24Letrozole 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Atorvastatin × Clear all
NCT03819101 2026-05-06

PEACE-4

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting
1,210 enrolled
Genitourinary

Prostatic Neoplasms

NCT05796973 2025-06-27

MOVES

Tampere University Hospital

Phase 3 Recruiting
240 enrolled
BreastGenitourinaryGynecologic

Breast Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms

NCT04601116 2021-01-14

The MASTER Study (MAmmary Cancer STatin ER Positive Study)

Aarhus University Hospital

Phase 3 Recruiting
3,360 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡